T. Chan

发表

4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor.

P. Leeson, A. Foster, S. Grimwood, 1992, Journal of medicinal chemistry.

Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.

S. Sheikh, T. Bohnert, P. Schroeder, 2020, Journal of medicinal chemistry.

3-Nitro-3,4-dihydro-2(1H)-quinolones. Excitatory amino acid antagonists acting at glycine-site NMDA and (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

J. Kemp, P. Leeson, C. Moyes, 1993, Journal of medicinal chemistry.

Potent PDZ-Domain PICK1 Inhibitors that Modulate Amyloid Beta-Mediated Synaptic Dysfunction

R. Huganir, K. Rhodes, K. Guckian, 2018, Scientific Reports.

Synapto‐depressive effects of amyloid beta require PICK1

R. Huganir, R. Malinow, K. Rhodes, 2014, The European journal of neuroscience.

Tyrosine kinase inhibitors pyrimidinyl

Xiangli Shi, Ross A. Miller, A. Thompson, 2013 .